Is Edrophonium regularly used in modern medical practice?

Edrophonium is a short-acting reversible inhibitor of the enzyme acetylcholinesterase and has specific clinical applications, notably in the diagnosis of myasthenia gravis. However, its use in modern medical practice has diminished over time due to the availability of more effective and longer-acting cholinesterase inhibitors. While edrophonium may still be used in certain situations, such as a diagnosis or during specific clinical evaluations, it is not a routinely used treatment in daily practice.

Most practitioners prefer alternative therapies that provide a more sustainable and effective management of conditions related to cholinergic function, such as myasthenia gravis. Consequently, the statement that edrophonium is not regularly used in modern medical practice reflects its limited role and the evolution of treatment options available today.